What Researchers Did
Researchers designed and tested a tympanometry-based anti-barotrauma (ABT) device to objectively prevent middle ear barotrauma during hyperbaric oxygen therapy.
What They Found
They found that when pressure increased above 200 daPa, eardrum admittance decreased to 16.255% of prepressurization levels. After pressure equalization, eardrum admittance recovered to 95.595% of prepressurization levels, indicating the device could monitor equalization status.
What This Means for Canadian Patients
This device could potentially provide real-time feedback on middle ear pressure during hyperbaric oxygen therapy, helping to prevent painful barotrauma before it occurs. This might lead to more comfortable treatments and reduce the number of patients discontinuing therapy due to ear pain.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The abstract does not explicitly state limitations, but this initial study likely requires further clinical validation in a larger patient cohort.